Global Custom Market Research Reports Provider Company

phone

Syros Pharmaceuticals Inc (SYRS) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America
Summary

Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The companys pipeline products include SY-1425, an oral, potent and selective RARa agonist that are used to treat patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). It also provides SY-1365, potent and selective small molecule inhibitor of CDK7 that are used to treat patients with transcriptionally driven solid tumors and acute leukemias. Syors offers services such as gene regulation, new medicines development, genes control, proprietary drug development platform, integrated gene control assay technologies, and computational biology, chemistry, and deep biologic insights solutions. Its gene control platform identifies novel gene control targets linked to genomically defined patient populations, and drugging gene control targets. The company seeks to work in partnership with others biopharmaceutical companies to extend the potential of our gene control platform across multiple therapeutic areas and diseases. Syros is headquartered in Cambridge, Massachusetts, the US.

Syros Pharmaceuticals Inc Key Recent Developments

Nov 08,2017: Syros Reports Third Quarter 2017 Financial Results and Highlights Accomplishments and Upcoming Milestones
Oct 26,2017: Syros Drug Discovery Research in Immuno-Oncology Highlighted in Oral Presentation at American College of Surgeons Clinical Congress
Oct 20,2017: Syros Announces Oral Presentation Highlighting Its Drug Discovery Research in Immuno-Oncology at American College of Surgeons Clinical Congress
Aug 09,2017: Syros Reports Second Quarter 2017 Financial Results and Highlights Accomplishments and Upcoming Milestones
Jun 19,2017: Syros Presents Discovery of Key Genes Controlling the Autoimmune Response in Lupus in Late-Breaking Oral Presentation at FOCIS Meeting

This comprehensive SWOT profile of Syros Pharmaceuticals Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Syros Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



Syros Pharmaceuticals Inc - Key Information

Syros Pharmaceuticals Inc - Overview

Syros Pharmaceuticals Inc - Key Employees

Syros Pharmaceuticals Inc - Key Employee Biographies

Syros Pharmaceuticals Inc - Key Operational Heads

Syros Pharmaceuticals Inc - Major Products and Services

Syros Pharmaceuticals Inc - History

Syros Pharmaceuticals Inc - Company Statement

Syros Pharmaceuticals Inc - Locations And Subsidiaries

Syros Pharmaceuticals Inc - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



Syros Pharmaceuticals Inc - Business Description

Syros Pharmaceuticals Inc - Corporate Strategy

Syros Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Syros Pharmaceuticals Inc - Strengths

Syros Pharmaceuticals Inc - Weaknesses

Syros Pharmaceuticals Inc - Opportunities

Syros Pharmaceuticals Inc - Threats

Syros Pharmaceuticals Inc - Key Competitors



Section 3 - Company Financial Performance Charts



Syros Pharmaceuticals Inc - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




Syros Pharmaceuticals Inc, Key Information

Syros Pharmaceuticals Inc, Key Ratios

Syros Pharmaceuticals Inc, Share Data

Syros Pharmaceuticals Inc, Major Products and Services

Syros Pharmaceuticals Inc, History

Syros Pharmaceuticals Inc, Key Employees

Syros Pharmaceuticals Inc, Key Employee Biographies

Syros Pharmaceuticals Inc, Key Operational Heads

Syros Pharmaceuticals Inc, Other Locations

Syros Pharmaceuticals Inc, Subsidiaries

Syros Pharmaceuticals Inc, Key Manufacturing facilities

Syros Pharmaceuticals Inc, Key Competitors

Syros Pharmaceuticals Inc, SWOT Analysis

Syros Pharmaceuticals Inc, Ratios based on current share price

Syros Pharmaceuticals Inc, Annual Ratios

Syros Pharmaceuticals Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




Syros Pharmaceuticals Inc, Performance Chart

Syros Pharmaceuticals Inc, Ratio Charts

Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The companys pipeline products include SY-1425, an oral, potent

View Report

Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The companys pipeline products include SY-1425, an oral, potent

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports